a2 Milk Company Limited
Recent
price
P/E
ratio
div
yld
2.67%
ROIC.AI
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Semi-annual Revenue
•
in mil. unless spec.Semi-annual Earnings Per Share
•
in mil. unless spec.Semi-annual Dividends Per Share
•
in mil. unless spec.- Similar Companies
- Business
- The a2 Milk Company Limited (ATM.NZ) is a dairy nutritionals company that specializes in premium branded products containing only the A2 beta-casein protein type, sourced from cows that naturally produce milk free of the A1 protein; it offers fresh liquid milk, including the market-leading a2 Milk brand in Australia; infant milk formula (IMF) such as a2 Platinum, a2 Genesis, and a2 Gentle Gold under English label and China label registrations; kids fortified functional milk powder; other nutritional products for infants, children, and seniors; and nutritional ingredients, while providing royalty, licensing, and rent services. The company operates in key markets including Australia and New Zealand, Greater China (its primary revenue source), North America, and emerging markets, with trading activities focused on these regions. Founded in 2000 and headquartered in Auckland, New Zealand, it maintains dual listings on the NZX and ASX, with additional offices in Sydney, Melbourne, and Boulder, Colorado. In recent developments, the company acquired Yashili New Zealand Dairy Co. Limited, including the Pokeno manufacturing facility in Waikato, New Zealand, from Yashili International Group (a China Mengniu Dairy subsidiary) for NZ$282 million on a debt- and cash-free basis in August 2025, securing two existing China label IMF registrations and planning a further NZ$100 million investment to expand capacity, create over 100 jobs, and support ultra-premium organic IMF with DHA and ARA; it simultaneously divested its 75% stake (and facilitated the sale of China Animal Husbandry Group's 25%) in Mataura Valley Milk to Open Country Dairy for net proceeds of approximately NZ$100 million, optimizing its manufacturing footprint while retaining supply access via commercial agreement. These transactions advance its supply chain transformation strategy, reported alongside FY2025 results showing net profit of NZ$202.9 million (up 21%), EBITDA of NZ$274.3 million (up 17.1%), and IMF sales growth of 10%, driven by 17% English label expansion and China label growth. The company targets FY2026 operating margins of 15-16% and continues launching products in infant, kids, and seniors nutrition segments, including entry into Vietnam's IMF market, while initiating shareholder returns with first-ever dividends totaling 20 cents per share for FY2025.
Company News
The a2 Milk Company Limited (ACOPY) Q4 2026 Earnings Call Transcript
a2 Milk H1 Earnings Call Highlights
The a2 Milk Company Limited (ACOPY) Q2 2026 Earnings Call Transcript
a2 Milk (OTCMKTS:ACOPF) Trading 8% Higher – Still a Buy?
The a2 Milk Company Limited (ACOPY) Shareholder/Analyst Call Transcript
The a2 Milk Company Limited (ACOPF) Q4 2025 Earnings Call Transcript
The a2 Milk Company: Multiple External And Internal Catalysts (Rating Upgrade)
The a2 Milk Company Limited (ACOPF) Q2 2025 Earnings Call Transcript
The a2 Milk Company Limited (ACOPF) Q4 2024 Earnings Call Transcript
The a2 Milk Company Limited (ACOPF) Q2 2024 Earnings Call Transcript
The a2 Milk Company Limited (ACOPF) Q4 2023 Earnings Call Transcript
The 7 Hottest Penny Stocks You Can Buy Today For A Rebound Tomorrow